You are here: Industry Insights > Pfizer

News List

Pfizer’s Lorbrena scores US priority review pharmatimes
January 05, 2021
Pfizer’s tyrosine kinase inhibitor (TKI) Lorbrena (lorlatinib) has scored a US Food and Drug Administration (FDA) priority review for the first-line treatment of anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC).
Pfizer, BioNTech to Supply the EU with 100 mn additional COVID-19 vaccine doses expresspharma
December 31, 2020
Total doses ordered reaches 300 million for 27 EU member states, all 300 million doses expected to be delivered in 2020 and 2021.
Pfizer, BioNTech to Supply U.S. With 100 Million Additional Doses of Covid-19 Vaccine americanpharmaceuticalreview
December 24, 2020
Pfizer and BioNTech have announced a second agreement with the U.S. government to supply an additional 100 million doses of the companies’ COVID-19 Vaccine from production facilities in the U.S.
Pfizer, BioNTech win EU authorisation for COVID-19 vaccine Comirnaty pharmatimes
December 23, 2020
The European Commission (EC) has granted Pfizer/BioNTech’s COVID-19 vaccine a conditional marketing authorisation (CMA), under the new name Comirnaty.
Pfizer, BioNTech Receive CHMP Positive Opinion for COVID-19 Vaccine americanpharmaceuticalreview
December 23, 2020
Pfizer and BioNTech announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion to recommend the conditional marketing authorization (CMA) of the Pfizer-BioNTech COVID-19 vaccine ...
BioNTech-Pfizer vaccine heads to EU as effectiveness against new strain tested expresspharma
December 23, 2020
The European Union is gearing up for a vaccination campaign of unprecedented scale following regulatory approval for the shot on Monday.
FDA investigates allergic reactions of Pfizer Covid-19 vaccine in US pharmaceutical-technology
December 22, 2020
The US Food and Drug Administration (FDA) has started investigating around five allergic reactions that occurred after individuals received Pfizer and BioNTech’s Covid-19 shot.
Pfizer and BioNTech get EU authorisation for COVID-19 Vaccine expresspharma
December 22, 2020
Pfizer and BioNTech announced that the European Commission (EC) has granted a conditional marketing authorisation (CMA) to Pfizer and BioNTech for COMIRNATY (also known as BNT162b2), for active immunisation to prevent COVID-19 caused by SARS-CoV-2 ...
Pfizer’s COVID-19 vaccine data accessed in EMA cyber-attack europeanpharmaceuticalreview
December 15, 2020
Pfizer and BioNTech told that documents relating to their COVID-19 vaccine approval were accessed during a cyber-attack on the European Medicines Agency (EMA).
Safety and efficacy data from Phase III trial of BNT162b2 vaccine published europeanpharmaceuticalreview
December 15, 2020
Pfizer and BioNTech’s data on BNT162b2, their COVID-19 vaccine, has been published in a new scientific paper, demonstrating its 95 percent efficacy rate.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 83 84 Next page